Pharnext SA
Pharnext S.C.A., a clinical-stage biopharmaceutical company, engages in developing novel therapies for neurodegenerative diseases. Its products in clinical development include PXT3003, a synergistic combination of baclofen, naltrexone, and sorbitol formulated as an oral solution for the treatment of charcot-marie-tooth disease type 1A; and PXT864, a novel fixed-dose synergistic combination of bac… Read more
Pharnext SA (PNEXF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2022: 0.226x
Based on the latest financial reports, Pharnext SA (PNEXF) has a cash flow conversion efficiency ratio of 0.226x as of June 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.52 Million) by net assets ($-24.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pharnext SA - Cash Flow Conversion Efficiency Trend (2015–2022)
This chart illustrates how Pharnext SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pharnext SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharnext SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vatic Ventures Corp.
PINK:VCVVF
|
0.002x |
|
NISOURCE (NOU.SG)
STU:NOU
|
0.033x |
|
Nykredit Invest Balance Mod KL
CO:NBIMOKL
|
N/A |
|
NexOptic Technology Corp
PINK:NXOPF
|
-0.011x |
|
FIRSTENERGY - Dusseldorf Stock Exchang
DU:FE7
|
0.057x |
|
Ralliant Corporation Common Stock
NYSE:RAL
|
0.047x |
|
AUBAY (BAQ.SG)
STU:BAQ
|
N/A |
|
Search Minerals Inc
PINK:SHCMF
|
-0.009x |
Annual Cash Flow Conversion Efficiency for Pharnext SA (2015–2022)
The table below shows the annual cash flow conversion efficiency of Pharnext SA from 2015 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-34.38 Million | $-25.34 Million | 0.737x | -44.56% |
| 2021-12-31 | $-17.86 Million | $-23.73 Million | 1.329x | +3.47% |
| 2020-12-31 | $-12.52 Million | $-16.08 Million | 1.285x | -56.84% |
| 2019-12-31 | $-7.25 Million | $-21.57 Million | 2.977x | +392.87% |
| 2018-12-31 | $-26.35 Million | $-15.91 Million | 0.604x | -61.49% |
| 2017-12-31 | $-11.99 Million | $-18.80 Million | 1.568x | +147.48% |
| 2016-12-31 | $3.80 Million | $-12.55 Million | -3.303x | -953.37% |
| 2015-12-31 | $-23.70 Million | $-9.17 Million | 0.387x | -- |